chr22-37735039-C-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001039141.3(TRIOBP):āc.4703C>Gā(p.Ala1568Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,608,426 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001039141.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIOBP | NM_001039141.3 | c.4703C>G | p.Ala1568Gly | missense_variant | 9/24 | ENST00000644935.1 | NP_001034230.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.4703C>G | p.Ala1568Gly | missense_variant | 9/24 | NM_001039141.3 | ENSP00000496394 | A2 | ||
TRIOBP | ENST00000344404.10 | c.*4186C>G | 3_prime_UTR_variant, NMD_transcript_variant | 7/22 | 2 | ENSP00000340312 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152090Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000235 AC: 58AN: 246980Hom.: 2 AF XY: 0.000268 AC XY: 36AN XY: 134468
GnomAD4 exome AF: 0.000117 AC: 170AN: 1456218Hom.: 3 Cov.: 36 AF XY: 0.000153 AC XY: 111AN XY: 723356
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74432
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 28, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Ala1568Gly va riant in TRIOBP has not been previously reported in individuals with hearing los s, but has been identified in 0.2% (32/16342) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs5699 14227). Alanine (Ala) at position 1568 is not conserved in mammals or evolutiona rily distant species and at least 1 mammal (elephant) carries a glycine (Gly), s upporting that this change may be tolerated. Additional computational prediction tools do not provide strong support for or against an impact to the protein. In summary, while the clinical significance of the p.Ala1568Gly variant is uncerta in, its frequency in the general population and lack of conservation suggest tha t it is more likely to be benign. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 22, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at